Literature DB >> 2332903

Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay.

S A Fuqua1, N F Falette, W L McGuire.   

Abstract

We developed a simplified polymerase chain reaction (PCR) technique sensitive enough to detect estrogen receptor (ER) mRNA in breast tumor specimens from 1 microgram of total RNA. We simultaneously amplified a control gene such as beta-actin as a baseline to semiquantitate ER expression. In a preliminary test of this method on a small series of breast tumors, ER message was found as expected in a number of tumors found to be ER positive by ligand binding assay, but also ER negative in one tumor assayed. The ER in this last tumor contained a single base change in the hormone binding region, compared with the MCF-7 breast tumor cell line ER. Therefore, this PCR technique may be useful in the detection and cloning of rare ER transcripts from breast tumor biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332903     DOI: 10.1093/jnci/82.10.858

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer.

Authors:  S Chevillard; A Müller; C Levalois; C Lainé-Bidron; P Vielh; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines.

Authors:  R Zeillinger; E Tantscher; C Schneeberger; W Tschugguel; S Eder; G Sliutz; J C Huber
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.

Authors:  S Trivedi; M Piccart; C Muquardt; N Gilot; S Hadiy; D Patel; G Leclercq
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Steroid hormone receptors and their clinical significance in cancer.

Authors:  R I Nicholson; R A McClelland; J M Gee
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

5.  Incidence of an estrogen receptor polymorphism in breast cancer patients.

Authors:  R K Schmutzler; M Sanchez; S Lehrer; C A Chaparro; C Phillips; J Rabin; B Schachter
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

6.  Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction.

Authors:  U Lönn; S Lönn; U Nylen; B Stenkvist; B Vennström
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Analysis of epidermal growth factor receptor mRNA expression by polymerase chain reaction assay in 94 human breast adenocarcinoma tumors.

Authors:  N S Falette; N Artagaveytia; M C Rostan; E Garin; J Y Bobin; S Saez
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7.

Authors:  J J Pink; S Q Wu; D M Wolf; M M Bilimoria; V C Jordan
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

9.  Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients.

Authors:  N O Funaki; J Tanaka; G Ohshio; H Onodera; S Maetani; M Imamura
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract.

Authors:  T Enomoto; M Fujita; C Cheng; R Nakashima; M Ozaki; M Inoue; T Nomura
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.